8-38057220-G-A
Variant names:
Variant summary
Our verdict is Benign. The variant received -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2
The NM_004095.4(EIF4EBP1):c.285G>A(p.Gln95Gln) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0125 in 1,614,060 control chromosomes in the GnomAD database, including 157 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0093 ( 10 hom., cov: 34)
Exomes 𝑓: 0.013 ( 147 hom. )
Consequence
EIF4EBP1
NM_004095.4 synonymous
NM_004095.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.212
Genes affected
EIF4EBP1 (HGNC:3288): (eukaryotic translation initiation factor 4E binding protein 1) This gene encodes one member of a family of translation repressor proteins. The protein directly interacts with eukaryotic translation initiation factor 4E (eIF4E), which is a limiting component of the multisubunit complex that recruits 40S ribosomal subunits to the 5' end of mRNAs. Interaction of this protein with eIF4E inhibits complex assembly and represses translation. This protein is phosphorylated in response to various signals including UV irradiation and insulin signaling, resulting in its dissociation from eIF4E and activation of mRNA translation. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -17 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.7).
BP6
Variant 8-38057220-G-A is Benign according to our data. Variant chr8-38057220-G-A is described in ClinVar as [Benign]. Clinvar id is 774460.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.212 with no splicing effect.
BS2
High AC in GnomAd4 at 1417 AD gene.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00931 AC: 1417AN: 152212Hom.: 10 Cov.: 34 show subpopulations
GnomAD3 genomes
AF:
AC:
1417
AN:
152212
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00940 AC: 2359AN: 250876 AF XY: 0.00931 show subpopulations
GnomAD2 exomes
AF:
AC:
2359
AN:
250876
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0129 AC: 18802AN: 1461730Hom.: 147 Cov.: 32 AF XY: 0.0124 AC XY: 9045AN XY: 727162 show subpopulations
GnomAD4 exome
AF:
AC:
18802
AN:
1461730
Hom.:
Cov.:
32
AF XY:
AC XY:
9045
AN XY:
727162
Gnomad4 AFR exome
AF:
AC:
55
AN:
33478
Gnomad4 AMR exome
AF:
AC:
285
AN:
44714
Gnomad4 ASJ exome
AF:
AC:
829
AN:
26120
Gnomad4 EAS exome
AF:
AC:
0
AN:
39696
Gnomad4 SAS exome
AF:
AC:
413
AN:
86248
Gnomad4 FIN exome
AF:
AC:
153
AN:
53408
Gnomad4 NFE exome
AF:
AC:
16092
AN:
1111912
Gnomad4 Remaining exome
AF:
AC:
900
AN:
60386
Heterozygous variant carriers
0
1074
2148
3222
4296
5370
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
630
1260
1890
2520
3150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00930 AC: 1417AN: 152330Hom.: 10 Cov.: 34 AF XY: 0.00913 AC XY: 680AN XY: 74490 show subpopulations
GnomAD4 genome
AF:
AC:
1417
AN:
152330
Hom.:
Cov.:
34
AF XY:
AC XY:
680
AN XY:
74490
Gnomad4 AFR
AF:
AC:
0.00288628
AN:
0.00288628
Gnomad4 AMR
AF:
AC:
0.00810246
AN:
0.00810246
Gnomad4 ASJ
AF:
AC:
0.032872
AN:
0.032872
Gnomad4 EAS
AF:
AC:
0.000192901
AN:
0.000192901
Gnomad4 SAS
AF:
AC:
0.00662252
AN:
0.00662252
Gnomad4 FIN
AF:
AC:
0.00442395
AN:
0.00442395
Gnomad4 NFE
AF:
AC:
0.013746
AN:
0.013746
Gnomad4 OTH
AF:
AC:
0.00803403
AN:
0.00803403
Heterozygous variant carriers
0
74
148
223
297
371
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Asia WGS
AF:
AC:
16
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Dec 31, 2019
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
Mutation Taster
=100/0
polymorphism
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at